期刊文献+

中国人群1型糖尿病人类白细胞抗原-DR基因多态性的Meta分析 被引量:3

Meta-analysis on the HLA-DR gene polymorphisms of T1DM in Chinese populations
原文传递
导出
摘要 目的评价中国人群人类白细胞抗原(HLA)-DR基因多态性与T1DM的关联性。方法在T1DM病例组与健康对照组间比较HLA-DR基因位点的比值比(OR)。联合检索中华医学会系列期刊、CNKI数据库、中国科技期刊数据库和Pubmed获得全部相关文献,剔除不符合纳入标准的文献。应用Meta分析软件包REVMAN 5.0统计相关基因位点的OR值,同时评估发表偏倚。结果中国人群中,DR3、DR4、DRB1*0301和DRB1*0405是易感性基因(P均<0.05),总OR值分别为4.42、2.18、6.04和3.21。DR2、DR6、DR15和DRB1*1101是保护性基因(P<0.05),总OR值分别为0.31、0.50、0.51和0.35。危险基因型为DR3/DR4和DR3/DR9(P<0.05),总OR值分别为25.36和5.21。结论在中国人群中,一些与T1DM关联的HLA-DR与国外对其他国家人群的研究报道不尽相同。DR3、DR4、DRB1*0301、DRB1*0405、DR3/DR4和DR3/DR9在多个种族人群中均表现为易感性,与本研究一致;而DR2的保护性效应也与本研究结果较为一致,其余则差异有统计学意义。 Objective To evaluate the relationship between the allele polymorphism of HLA-DR and T1DM in the Chinese populations. Methods The odds ratios (OR) of HLA-DR allele distributions in T1DM patients were analyzed against healthy controls. All the relevant studies in Wanfang Data, CNKI, Chinese Science and Technology Periodical Database VIP Information, and Pubmed were identified, and poorly qualified studies were excluded. The meta-analysis software REVMAN 5.0 was applied for summarizing OR of relevant alleles in all the studies. The publication bias was also evaluated. Results DR3, DR4, DRB1 * 0301, and DRB1 * 0405 were the susceptible alleles (all P〈0. 05) in the Chinese populations,their merger OR were 4.42, 2.18, 6.04, and 3.21 respectively. DR2, DR6, DR15, and DRB1 * 1101 were the protective alleles (P〈0. 05), and their merger OR were 0. 31, 0.50, 0. 51, and 0. 35 respectively. DR3/DR4 and DR3/DR9 were also the susceptible genotypes (P〈0. 05), and their merger OR were 25.36 and 5.21 respectively. Conclusion In the Chinese populations, some HLA-DR alleles relevant to T1DM are not totally the same as in the reports on non-Chinese populations. Susceptible alleles in China such as DR3, DR4, DRB1 * 0301, DRB1 * 0405, DR3/DR4, and DR3/DR9 match those of the non-Chinese populations, while the protective DR2 also agrees with the non-Chinese ones. And other alleles are quite different.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2012年第12期889-893,共5页 Chinese Journal of Diabetes
基金 上海市科学技术委员会基金资助项目(11ZR1432000)
关键词 糖尿病 1型 HLA-DR基因位点 META分析 基因多态性 Diabetes mellitus, type 1 Human leucocyte antigen (HLA)-DR alleles Meta- analysis Allele polymorphism
  • 相关文献

参考文献11

二级参考文献43

共引文献29

同被引文献56

  • 1李蕾,马杉,薛元明.2型糖尿病患者的细胞免疫功能研究[J].中国误诊学杂志,2007,7(25):5962-5963. 被引量:16
  • 2S?rensenJS, JohannesenJ, PociotF, et al. Residual β-cell function 3-6 years after onset of type 1 diabetes reduces risk of severe hypoglycemia in children and adolescents[J]. Diabetes Care, 2013,36(11):3454-3459. DOI: 10.2337/dc13-0418.
  • 3SteffesMW, SibleyS, JacksonM, et al. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial[J]. Diabetes Care, 2003,26(3):832-836.
  • 4Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group[J]. Ann Intern Med, 1998,128(7):517-523. DOI: 10.7326/0003-4819-128-7-199804010-00001.
  • 5MortensenHB, SwiftPG, HollRW, et al. Multinational study in children and adolescents with newly diagnosed type 1 diabetes: association of age, ketoacidosis, HLA status, and autoantibodies on residual beta-cell function and glycemic control 12 months after diagnosis[J]. Pediatr Diabetes, 2010,11(4):218-226. DOI: 10.1111/j.1399-5448.2009.00566.x.
  • 6American Diabetes Association. Diagnosis and classification of diabetes mellitus[J]. Diabetes Care, 2010,33(Suppl 1):S62-S69. DOI: 10.2337/dc10-S062.
  • 7GreenbaumCJ, BeamCA, BoulwareD, et al. Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data[J]. Diabetes, 2012,61(8):2066-2073. DOI: 10.2337/db11-1538.
  • 8LiX, HuangG, LinJ, et al. Variation of C peptide decay rate in diabetic patients with positive glutamic acid decarboxylase antibody: better discrimination with initial fasting C peptide[J]. BMC Endocr Disord, 2013,13:10. DOI: 10.1186/1472-6823-13-10.
  • 9FernandezCM, Monta?aE, CampsI, et al. Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes[J]. Diabetes Metab, 1996,22(5):349-355.
  • 10FredheimS, JohannesenJ, JohansenA, et al. Diabetic ketoacidosis at the onset of type 1 diabetes is associated with future HbA1c levels[J]. Diabetologia, 2013,56(5):995-1003. DOI: 10.1007/s00125-013-2850-z.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部